Unlock instant, AI-driven research and patent intelligence for your innovation.

Tagged swine fever virus e2 protein recombinant baculovirus inactivated vaccine

A technology of recombinant baculovirus and swine fever virus, applied in the field of vaccines, can solve problems affecting vaccine safety, contaminated cattle viral diarrhea, and uneven quality of antigens

Active Publication Date: 2022-07-29
天康生物制药有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The first production method requires a large number of rabbits to collect antigens. In addition, due to the influence of individual differences in rabbits, the quality of antigens is uneven, which ultimately affects the effect of the vaccine.
The second production method requires the use of bovine serum in the production process. Bovine serum not only introduces heterologous animal protein into the product, but also may contaminate bovine viral diarrhea, which affects the safety of the vaccine.
Immunization with swine fever E2 subunit vaccine twice can produce effective protection under virulent attack; although it can be differentially diagnosed by swine fever Erns antibody, due to the short duration of Erns antibody and even some strains cannot produce Erns antibody, it is necessary to use Erns antibody ineffective differential diagnosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tagged swine fever virus e2 protein recombinant baculovirus inactivated vaccine
  • Tagged swine fever virus e2 protein recombinant baculovirus inactivated vaccine
  • Tagged swine fever virus e2 protein recombinant baculovirus inactivated vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0071] Embodiment 1 Swine fever virus E2 gene optimization, mutation and synthesis

[0072]The published E2 sequences of swine fever virus and the E2 sequences of new strains popular in recent years were downloaded from Genebank for reference, and the E2 gene of strain C was optimized based on the optimized E2 gene and the reference strains of each subgroup. The alignment was performed, and the results showed that the optimized E2 gene was identified as group 1.1. At the same time, the optimized E2 gene sequence epitope "TAVSPTTLR" was mutated to "ATVSPTTRL, TASVPTTLR, TAVSTPTLR, TAVSPTTRL, TAPVSTTRL or TASPVTTRL", and the obtained 6 optimized mutated sequences were handed over to Gene Company for synthesis.

Embodiment 2

[0073] The construction of embodiment 2 transfer vector

[0074] The test method is referred to the Invitrogen operation manual, and the specific operation is described as follows.

[0075] formulate The clone reaction mixture has the following components: 0.5-4µl of synthesized E2 nucleotides, 1µl of salt solution (1.2mol / LNaCl, 0.06mol / LMgCl2)), 1µl carrier, and double-distilled water was added to bring the total volume to 6 μl. The steps of the cloning reaction are as follows: tap the wall of the centrifuge tube to make the reaction mixture evenly mixed, leave it at room temperature (22-23°C) for 15 minutes, and place the reaction tube on ice. Take 2μl Add the clone reaction solution to the competent cells, tap the tube wall to mix evenly, put it on ice for 30 minutes, then place it in a 42°C water bath for 30 seconds for heat shock, and immediately put the reaction tube back on ice. Then, 250 μl of the warmed SOC culture medium was added to the reaction tube, and i...

Embodiment 3

[0077] Example 3 Recombination of transfer vector and linear baculovirus

[0078] The extracted recombinant vector was used to measure the nucleic acid concentration of the recombinant vector with a spectrophotometer at a wavelength of 260 nm. The LR recombination reaction was carried out according to the operation manual of "BaculoDirectTM Baculovirμs Expression System" provided by Invitrogen. The specific operations are as follows: aseptically transfer 1 μl of recombinant transfer vector (100-300 ng), 4 μl of 5×LR The reaction buffer and 1 μl of double-distilled water were added to 10 μl of BaculoDirectTM linear DNA (300 ng), respectively. Remove LR from -70°C freezer The enzyme mix was placed on ice and warmed for 2 minutes, shaken twice, 2 seconds each time, and 4 μl LR was taken. Add the enzyme mix to the above mixture, tap the tube wall several times to mix evenly, do not shake vigorously to avoid baculovirus DNA breakage. After 18 hours at 25°C, 2 µl of proteinas...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of vaccines, and in particular, provides a recombinant baculovirus inactivated vaccine marked with E2 protein of swine fever virus. The present invention provides the marked swine fever virus recombinant E2 protein of SEQ ID NO. 1, and the nucleic acid molecule sequence encoding it is shown in SEQ ID NO. 2. The baculovirus-insect cell expression system can achieve high-efficiency expression of the target protein, and the marker The swine fever virus recombinant E2 protein can be used to prepare a recombinant baculovirus inactivated vaccine marked with the swine fever virus E2 protein, and it only needs to be immunized once to have immune efficacy equivalent to subunit vaccines and live vaccines. In addition, the detection of WH303 antibody can be used to identify pigs infected with non-labeled vaccine strains or wild virus strains, so as to achieve effective purification of swine fever.

Description

technical field [0001] The present invention relates to the field of vaccines, in particular to a recombinant baculovirus inactivated vaccine marked with E2 protein of swine fever virus. Background technique [0002] At present, there are three production methods for conventional swine fever vaccine. One is to inoculate the seed virus in healthy rabbits to breed in the body, and then collect the spleen and lymph nodes of the rabbits and grind them to freeze-dry. The second is to inoculate the seed virus into primary cells or passaged cells, collect the supernatant and freeze-dry it. The first production method requires a large number of rabbits to collect antigens. In addition, due to the influence of individual differences in rabbits, the quality of antigens is uneven, which ultimately affects the effect of vaccines. The second production method requires bovine-derived serum in the production process. Bovine-derived serum not only introduces heterologous animal protein int...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/18C12N15/40C12N7/01A61K39/187A61P31/14G01N33/569
CPCC07K14/005C12N7/00A61K39/12A61P31/14G01N33/56983C12N2800/22C12N2770/24322C12N2770/24334C12N2710/14021A61K2039/5252A61K2039/5256A61K2039/552G01N2333/183
Inventor 贺笋李俊辉王遵宝李延涛程兰玲刘宏郑侃王雨朦
Owner 天康生物制药有限公司